Aug 15 (Reuters) - Inozyme Pharma Inc INZY.O :
* INOZYME PHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATES
* INOZYME PHARMA - CASH, CASH EQUIVALENTS & INVESTMENTS AS
OF
QUARTER END, WITH FIRST TRANCHE OF DEBT FACILITY, FUNDS CASH
FLOW REQUIREMENTS INTO Q2 OF 2024
* NET LOSS WAS $15.3 MILLION, OR $0.38 LOSS PER SHARE, FOR
THE
QUARTER ENDED JUNE 30, 2022
* Q2 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX70snW0
Further company coverage: INZY.O